Substituted arylalkylamines are a group of chemical compounds. Two major classes of arylalkylamines include indolylalkylamines (e.g., tryptamines (a.k.a. indolylethylamines)) and phenylalkylamines (e.g., phenethylamines and amphetamines (a.k.a. phenylisopropylamines)), which consist of the monoamine neurotransmitters as well as clinically-used and recreationally-abused monoaminergic drugs, including psychostimulants, anorectics, wakefulness-promoting agents, bronchodilators, decongestants, antidepressants, entactogens, and psychedelics, among others.
- Glennon RA (October 1999). "Arylalkylamine drugs of abuse: an overview of drug discrimination studies". Pharmacol. Biochem. Behav. 64 (2): 251–6. doi:10.1016/S0091-3057(99)00045-3. PMID 10515299.
- Richard K. Ries; Shannon C. Miller; David A. Fiellin (2009). Principles of Addiction Medicine. Lippincott Williams & Wilkins. pp. 245–. ISBN 978-0-7817-7477-2.
- Thomas L. Lemke; David A. Williams (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 639–. ISBN 978-1-60913-345-0.
|This chemistry-related article is a stub. You can help Wikipedia by expanding it.|
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|